Real-time Estimate Cboe BZX 20:38:56 13/09/2024 BST 5-day change 1st Jan Change
26.78 USD +1.11% Intraday chart for Avantor, Inc. +3.28% +15.99%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
RBC Raises Price Target on Avantor to $34 From $31, Keeps Outperform Rating MT
Transcript : Avantor, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM
Wells Fargo Initiates Avantor at Overweight With $30 Price Target MT
Avantor to Sell Clinical Services Business to Audax Private Equity MT
Avantor to Divest Clinical Services Business to Audax Private Equity for $650 Million MT
Audax Management Company, LLC signed a definitive agreement to acquire the Clinical Services Business of Avantor, Inc. in a transaction valued at approximately $650 million. CI
Baird Adjusts Price Target on Avantor to $27 From $26, Maintains Outperform Rating MT
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care MT
Avantor's Shares Rise After Q2 Adjusted EPS Beat MT
Global markets live: Tesla, Take Two, Walt Disney, Colgate, Ford... Our Logo
Avantor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Transcript : Avantor, Inc., Q2 2024 Earnings Call, Jul 26, 2024
Avantor's Q2 Adjusted Earnings, Revenue Decline MT
Earnings Flash (AVTR) AVANTOR INC. Reports Q2 Revenue $1.70B, vs. Street Est of $1.70B MT
Earnings Flash (AVTR) AVANTOR INC. Reports Q2 EPS $0.25, vs. Street Est of $0.23 MT
Avantor, Inc.(NYSE:AVTR) added to S&P 1000 CI
Avantor, Inc.(NYSE:AVTR) added to S&P 400 Health Care CI
Avantor, Inc.(NYSE:AVTR) added to S&P Composite 1500 CI
Avantor, Inc.(NYSE:AVTR) added to S&P 400 CI
Avantor to Replace Quidel in S&P MidCap 400; Quidel to Replace Hibbett in S&P SmallCap 600 MT
RBC Lifts Price Target on Avantor to $31 From $30, Keeps Outperform Rating MT
Citigroup Downgrades Avantor to Neutral From Buy, Adjusts Price Target to $23 From $30 MT
Avantor, Inc. Announces the Departure of Frederic Vanderhaegen as Executive Vice President, Europe CI
Avantor, Inc. Announces New J. T. Baker Cell Lysis Solution and J. T. Baker Endonuclease CI
Chart Avantor, Inc.
More charts
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. Its segments include Laboratory Solutions and Bioscience Production. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, and biological safety cabinets. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
14,500
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.48USD
Average target price
28.57USD
Spread / Average Target
+7.91%
Consensus
  1. Stock Market
  2. Equities
  3. AVTR Stock
  4. News Avantor, Inc.
  5. Sector Update: Health Care Stocks Higher Late Afternoon
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW